Anne Rowling Clinic Researchers Share Their MS Research at MSToronto 2026

Anne Rowling Clinic MS researchers standing behind the MSToronto 2026 logo platform.

October 2026: Showcasing research, sharing knowledge, and helping to shape the future of multiple sclerosis research.

(Average reading time – 1 minutes) 

Researchers from the Anne Rowling Clinic joined the international multiple sclerosis (MS) research community at MSToronto2026, the 10th Joint ACTRIMS–ECTRIMS Meeting, held in Toronto, Canada, from 21–23 October 2026. 

The meeting brought together researchers, clinicians and healthcare professionals from around the world to share knowledge, discuss the latest scientific advances and support progress in MS research and care. 

The Anne Rowling MS research teams contributed through scientific session leadership, oral presentations and poster presentations. 

Dr Patrick Kearns presented his work on Epstein-Barr virus in early MS, while Professor David Hunt co-chaired the Meet the Expert scientific session, “Epstein-Barr Virus as a Treatment Target in MS”. 

PhD student Francesca Pentimalli Biscaretti Di Ruffia presented a research poster exploring the association between brain imaging findings and disability in relapsing-remitting MS. 

Professor Adam Waldman also presented an e-poster on behalf of Cassidy Power, titled “MONAI Model Outperforms a Standard Non-Machine Learning Method for Segmenting Choroid Plexus Volumes in Relapsing-Remitting Multiple Sclerosis”. 

Other posters explored the relationship between choroid plexus enlargement, inflammatory activity and neurodegeneration in early MS; the measurement of brain atrophy using standard-of-care MRI; and the use of quantitative microstructural MRI to predict future disability trajectories. 


Together, these contributions demonstrate the breadth of research at the Anne Rowling Clinic, spanning viral mechanisms, advanced neuroimaging, and disease progression. They also highlight the team's commitment to international collaboration and to advancing understanding of MS, with the long-term aim of improving outcomes for people living with the condition. 

The Clinic was also represented by Dr Don Mahad, Beth York, Dimitra Karagiannopoulou, Christine Farrugia, Dr Amin Mohamed Abu Baker and Dr Sarah-Jane Martin. 


Find out more 

MSToronto2026 – official meeting website 

Professor David Hunt's profile 

Profile for Dr Patrick Kearns

Francesca Pentimalli Biscaretti Di Ruffia (Google Scholar external website)

Professor Adam Waldman's profile

Discover our research: Find a Research Project

Find out how you can support our research:  Support Us

This article was published on: Thursday, 29 October, 2026
×